| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 26,106 | 27,325 | 25,164 | | Cost of Revenue | 17,843 | 20,814 | 16,780 | | | Gross Profit | 8,262 | 6,511 | 8,384 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 22,634 | 26,212 | 25,412 | | Non Recurring | 4,845 | 8,750 |
-
| | Others | 1,308 | 1,030 | 1,001 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (20,524) | (29,481) | (18,029) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 39 | 2,331 | 1,141 | | Earnings Before Interest And Taxes | (20,109) | (25,904) | (15,324) | | Interest Expense | 1,579 | 1,679 | 1,085 | | Income Before Tax | (21,688) | (27,584) | (16,409) | | Income Tax Expense | (148) | (148) | (148) | | Minority Interest | 228 | 1,098 | 1,267 | | | | Net Income From Continuing Ops | (21,688) | (27,584) | (16,557) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (21,688) | (27,584) | (16,557) | | Preferred Stock And Other Adjustments |
-
|
-
| (48) | | | Net Income Applicable To Common Shares | ($21,688) | ($27,584) | ($16,606) |
|
0.02% Nasdaq 
Income Statement
